Capacity Ramp Into Q3—Plant Commissioning Impact Still Ahead
Zelio E Mobility reports Q2 FY-2027 on 2026-11-13. The key watch: does management guide to higher output as the new Hisar facility (commissioned late October) begins scaling. With zero Street coverage and a customs duty notice shadowing the near term, this is about tracking execution vs. the fundraise thesis.
The Setup: Capacity in Motion
Zelio E Mobility is in the midst of a production footprint expansion. The headline: on October 28, 2026, the company commissioned its new manufacturing plant in Patan, Hisar, Haryana, adding 72,000 units of annual capacity to the EV two-wheeler lineup. This follows an earlier capacity increase at the Ladwa facility (Hisar), which jumped from 72,000 to 120,000 units per annum in February 2026. For Q2, the new plant was not operational—so this quarter's numbers should reflect pre-expansion run-rates. The real acceleration should emerge in Q3 onwards, once ramp curves tighten.
~₹80–90 Cr
Based on FY26 quarterly run-rate (~₹78 Cr/quarter avg); growth modest if new plant hasn't ramped yet
On-plan ramp expected
Hisar plant commissioned Oct 28; Q2 end inventory and demand hints at production flow into Q3
₹83 Cr preferential issue approved
Equity raise at ₹853/share; execution timeline a key guide signal
A strong Q2 print would show revenue in the ₹85–95 Cr range with flat or shrinking unit costs (operational gearing from the existing facilities), plus management confidence on Hisar ramp and the fundraise status. A weak print would flag slowing EV demand, margin pressure from unutilized capacity, or delays in fundraise execution—all would raise questions about the capex thesis.
On Track?
The company crossed ₹313 Cr in FY26 revenue, averaging ~₹78 Cr per quarter (before seasonal variation). With Hisar commissioned only in late October, Q2 will not yet show the full-run unit uplift. However, the board-approved preferential issue (₹82.99 Cr aggregate) and the operational milestone (plant live) are on the roadmap. Management's Q2 commentary—particularly on pre-orders into Q3 and fundraise timing—will be the litmus test for execution conviction. If the company is tracking guidance and the raise proceeds smoothly, the setup for Q3–Q4 acceleration is intact.
Since Last Quarter
1 · Hisar Plant Commissioned (Oct 28)
Commercial production at the Patan, Hisar facility is now live, adding 72,000 units/year. This is the single biggest operational milestone since the last report. Expect management to detail ramp trajectory and near-term utilization targets.
2 · Preferential Issue Approved (~₹83 Cr)
Board approved a preferential issue of 9,73,000 equity shares at ₹853 per share plus convertible warrants. Q2 commentary should clarify if shares are allotted, capital deployed, or still pending. Execution risk on guidance credibility.
3 · Customs Duty Notice (₹6.72 Cr Show-Cause)
In early August, Zelio received a customs duty show-cause notice from Delhi authorities proposing a differential duty demand of ₹6.72 Cr. No resolution publicly disclosed yet. On the call, investors will want clarity: is this a likely charge to Q2 P&L, a contingent liability, or still under review? Material for profitability if accrued.
4 · MD Re-appointed (Sep 30)
Kunal Arya continues as MD post-AGM, with no material corporate-governance changes. Secretarial Auditor also re-appointed for 5 years. Routine, no governance red flags.
5 · Ownership Shift: FII Outflow
FII holding fell from 3.42% (Q2 FY26) to 0.09% (Q4 FY26)—a 3.33 percentage-point decline. DII also retreated 8.75pp. Promoter stake steady at 72.77%. Street flows are cooling; retail/domestic money may be taking a lower profile. Watch for insider trading patterns into results.
What to Watch on Result Day
Unit economics and cost trajectory: How are margins moving? Is the new Hisar plant competitive on cost, or is pre-commissioning drag visible? Fundraise execution: Are the ₹83 Cr shares allocated? Are funds being deployed? Customs duty resolution: Has the ₹6.72 Cr notice been settled, accrued, or is it still pending? A charge to Q2 could sting. FY27 unit and revenue guidance: With Hisar live and 72,000 units of fresh capacity, what is management's full-year outlook? Is it translating to pre-orders? Debt and cash position: With capex in flight, how much headroom remains on the balance sheet?
Zelio E Mobility enters Q2 results as a small-cap, zero-coverage EV two-wheeler maker mid-expansion. The Hisar plant is now live, but its ramp will primarily show in Q3 and beyond; Q2 numbers should reflect the existing footprint baseline. The customs duty notice is a tail risk—if accrued, it could dent profits. On the upside, the preferential raise and new capacity signal management commitment to growth. With no Street consensus, the call is all about execution credibility and the FY27 unit/margin trajectory. Watch for evidence of demand momentum and fundraise progress. Price action is well-bid (₹1073.5, +384% from 52w low), but sentiment is thin; a cautious, data-driven read is warranted until coverage deepens or scale improves.